N Engl J Med 353 (26): 2747-57, 2005.[PUBMED Abstract] Coates AS, Keshaviah A, Th√ºrlimann B, et al.: Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
J Clin Oncol 25 (5): 486-92, 2007.[PUBMED Abstract] Boccardo F, Rubagotti A, Guglielmini P, et al.: Switching to anastrozole versus continued tamoxifen treatment of early breast cancer.
Updated results of the Italian tamoxifen anastrozole (ITA) trial.
Ann Oncol 17 (Suppl 7): vii10-4, 2006.[PUBMED Abstract] Jakesz R, Jonat W, Gnant M, et al.: Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.